To prevent MLM and prolong survival, our study identified PDE4D as a novel diagnostic and therapeutic target for CRC liver metastases and developed therapeutic strategies based on PDE4 inhibitors. The gene discussed is PDE4A; the disease is colorectal carcinoma.